Experimental Novartis drug slows kidney cancer

Category: Health

Publish Date: 05-16-2008 03:15 PM -0700

WASHINGTON (Reuters) - An experimental drug from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy, researchers reported on Friday.

Continue to Original Story >